Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

6 Stocks To Watch: CTRV, ENPH, PIRS, QD, TAL, ZYNE

Published 06/12/2019, 08:47 AM
Updated 07/09/2023, 06:31 AM

ContraVir Pharmaceuticals, Inc. (CTRV)

CTRV has a long declining channel, but in the last week there has been a huge change of events in terms of volume. CTRV had an explosive rally-pullback, then a pop-pullback, and then, finally, on Wednesday it had an explosive move again that took it up 2.50, or 36%, to 9.50, on a monster 2.7 million shares. It exploded to as high as 14.65, before settling back to 9.50. I am looking for this stock to get back above the 14.50 range. Anything above 15-15.50, and then we’re looking at a stock that could get to the low-to-mid 20’s. Keep an eye on this one.

Enphase Energy, Inc. (ENPH)

ENPH is one of the best-looking semiconductor stocks in the last year. It moved from the Sept low of about 3-3 1/4 to over 17 on Tuesday, up 88 cents, or 5.44%, to 17.07, on over 4 million shares, with a high of 17.15. It looks to me like this stock can run. The long-term channel as seen on the chart, indicates the possibility that now that it’s through resistance, it could run into the high 20’s. This is also one to keep an eye on for a potential swing trade.

Pieris Pharmaceuticals, Inc. (PIRS)

PIRS was just put out as a swing trade. I love the breakout, and the pullback-flag testing support. On Wednesday, it popped a little bit, up 10 cents, or 2.44%, to 4.19, on 533,683 shares traded, with a high of 4.22. The volume is picking up, and the technicals look good. I think that once it gets past the 4.70 range, you’re looking at 5 1/2 and 6 1/2 going forward.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Qudian Inc. (QD)

QD is also a swing trade currently in play. On Wednesday, it was up 38 cents, or 5.18%, to 7.71, on 6.5 million shares, closing just a penny off the high. The end of April it ran up to as high as 8.80, and then pulled back to 6.00. Since then, it formed a big wedge, and on Wednesday it broke out. There’s resistance above 7.71 at about 7 3/4. If it can get through that, we should see 8 1/2, and then 10.00.

TAL Education Group (TAL)

TAL one of my old swings from back in Nov, was trading at 26-27 and made it up to 39 before it pulled back. If you take a look at the pattern over the last 4-5 months, you’ll see that it is at key-key support right now in the 32-33 zone. Recently, it tested that level and broke out, Wednesday’s action took it out to key resistance at about 37 1/2, jumping 1.33, or 3.73%, to 37.00, on 4 million shares, with a high of 37.46. The volume pick-up was the best in five days. I think the next target is a retest of the May high at 39 1/2. I also think this has the potential to be in the mid ’40s.

Zynerba Pharmaceuticals, Inc. (ZYNE)

ZYNE was a swing of ours back in April when it broke out above 6 1/2. It worked out well by reaching both targets at 9 and 12, and even going further by reaching 16.47 back a month ago. The pullback recently tested the 50-day moving average and trendline and you can even see the snapback on Wednesday It popped 1.92, or 17%, to 13.50, on 6.8 million shares, with a high of 14.00. It looks like a breakout to me. I’m looking for a retest of the highs at 14, and the 20’s, possibly mid 20’s on an intermediate basis.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Stocks on the long side

CorMedix, Inc. (CRMD), ContraVir Pharmaceuticals, Inc. (CTRV), Enphase Energy, Inc. (ENPH), Huami Corporation (HMI), Pieris Pharmaceuticals, Inc. (PIRS), Qudian Inc. (QD), Stitch Fix, Inc. (SFIX), TAL Education Group (TAL), Telaria, Inc. (TLRA), Intrexon Corporation (XON), ZIOPHARM Oncology, Inc. (ZIOP), and Zynerba Pharmaceuticals, Inc. (ZYNE).

Watch video here.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.